Personalized Medicine in Cancer Research
This project analyses the impact of technological and structural change towards personalized medicine, specifically for product development by pharmaceutical manufacturers.
The focuses are on the costs of research and development, obtainable prices, and regulation processes fol-lowing authorization of technologies.
The following question will be answered: Under which preconditions do pharmaceutical manufacturers decide to develop products of personalized medicine?
April 2012 - April 2014
University Bochum (Duisburg-Essen) and Medizinische Hochschule Hannover